publication venue for
- Multiparameter flow cytometry in plasma cell disorders: when in doubt, go with the flow 2022
- High‐risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse 2021
- Prevalence of venous thromboembolism in critically ill patients with COVID‐19 2020
- Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial 2019